Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Correction to: The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of
Gita A Toyserkani1, Joann H Lee2, Esther H Zhou2
1Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Room 1106, Silver Spring, MD, 20993, USA. Gita.Toyserkani@fda.hhs.gov.
No abstract available in PubMed .
More Related Videos
09:34Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe
Published on: December 4, 2016
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Global Regulatory Systems
Types of Records II: Educational and Administrative Records
Drug Control Governance: Regulatory Bodies and Their Impact
Methods of Documentation VII: EMR